Hypofrontality in Neuroleptic-Naive Patients and in Patients With Chronic Schizophrenia: Assessment With Xenon 133 Single-Photon Emission Computed Tomography and the Tower of London

Archives of General Psychiatry

Volumn 49, Issue 12, 1992, Pages 943-958

  Andreasen, Nancy C ^a   Rezai, Karim ^a   Alliger, Randall ^a   Swayze, Victor W ^a   Flaum, Michael ^a   Kirchner, Peter ^a   Cohen, Gregg ^a   O'leary, Daniel S ^a  

^a UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT; XENON 133;

ADULT; ARTICLE; BRAIN BLOOD FLOW; CASE REPORT; CHRONIC DISEASE; CINGULATE GYRUS; FEMALE; FRONTAL CORTEX; HUMAN; MALE; PARIETAL LOBE; PRIORITY JOURNAL; SCHIZOPHRENIA; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TASK PERFORMANCE;

ADULT; ANTIPSYCHOTIC AGENTS; CEREBROVASCULAR CIRCULATION; CHRONIC DISEASE; FEMALE; FRONTAL LOBE; GYRUS CINGULI; HUMAN; MALE; NEUROPSYCHOLOGICAL TESTS; PARIETAL LOBE; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SEVERITY OF ILLNESS INDEX; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; XENON RADIOISOTOPES;

EID: 0026467216     PISSN: 0003990X     EISSN: 15383636     Source Type: Journal    
DOI: 10.1001/archpsyc.1992.01820120031006     Document Type: Article

References (87)

1. Nauta WJH. The problem of the frontal lobes: a reinterpretation. J Psychiatr Res. 1971;8:167-187.
2. Fuster JM. The Prefrontal Cortex. 2nd ed. New York, NY: Raven Press; 1990.
3. Stuss DT, Benson DF. The Frontal Lobes. New York, NY: Raven Press; 1986.
4. Goldman-Rakic PS, Selemon LD, Schwartz ML. Dual pathways connecting the dorsolateral prefrontal cortex with the hippocampal formation and parahippocampal cortex in the rhesus monkey. Neuroscience. 1984;12:719-743.
5. Kraepelin E; Barclay RM, Robertson GM, trans-eds. Dementia Praecox and Paraphrenia. Edinburgh, Scotland: E & S Livingstone; 1919.
6. Kety SS, Woodford RB, Harmel MH, Freyhan FA, Appel KE, Schmidt CF. Cerebral blood flow and metabolism in schizophrenia: the effects of barbiturate seminarcosis, insulin coma and electroshock. Am J Psychiatry. 1948;104:765-770.
7. Ingvar DH, Frazen G. Abnormalities of cerebral blood flow distribution in patients with chronic schizophrenia. Acta Psychiatr Scand. 1974;50:425-462.
8. Franzen G, Ingvar DH. Absence of activation in frontal structures during psychological testing of chronic schizophrenics. J Neurol Neurosurg Psychiatry. 1975;38:1027-1032.
9. Franzen G, Ingvar DH. Abnormal distribution of cerebral activity in chronic schizophrenia. J Psychiatr Res. 1975;12:199-214.
10. Mathew RJ, MeyerJS, Francis DJ, Schoolar JC, Weinman M, Mortel KF. Regional cerebral blood flow in schizophrenia: a preliminary report. Am J Psychiatry. 1981;138:112-113.
11. Mathew RJ, Duncan GC, Weinman ML, Barr DL. Regional cerebral blood flow in schizophrenia. Arch Gen Psychiatry. 1982;39:1121-1124.
12. Ariel RN, Golden CJ, Berg RA, Quaife MA, Dirkson JW, Forsell T, Wilson J, Graber B. Regional cerebral blood flow in schizophrenics. Arch Gen Psychiatry. 1983;40:258-263.
13. Gur RE, Skolnick BE, Gur RC. Brain function in psychiatric disorders, I: regional cerebral blood flow in medicated schizophrenics. Arch Gen Psychiatry. 1983;40:1250-1254.
14. Gur RE, Gur RC, Skolnick BE, Caroff S, Obrist WD, Resnick SM, Reivich M. Brain function in psychiatric disorders, III: regional cerebral blood flow in unmedicated schizophrenics. Arch Gen Psychiatry. 1985;42:329-334.
15. Devous MD Sr, Raese JD, Herman JH, Paulman RG, Gregory RR, Rush AJ, Chehabi HH, Bonte FJ. Regional cerebral blood flow in schizophrenic patients at rest and during Wisconsin card sort tasks. J Cereb Blood Flow Metab. 1985;5(suppl 1):S201-S202.
16. Kurachi M, Kobayashi K, Matsubara R, Hiramatsu H, Yamaguchi N, Matsuda H, Maeda T, Hisada K. Regional cerebral blood flow in schizophrenic disorders. Eur Neurol. 1985;24:176-181.
17. Warkentin S, Nilsson A, Karlson S, Risberg J, Flekkoy K, Franzen G, Gustafson L. Regional cerebral blood flow in schizophrenia and cycloid psychosis. J Cereb Blood Flow Metab. 1985;5(suppl 1):S185-S186.
18. Berman KF, Zec RF, Weinberger DR. Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia, II: role of neuroleptic treatment, attention, and mental effort. Arch Gen Psychiatry. 1986;43:126-135.
19. Chabrol H, Guell A, Bes A, Moron P. Cerebral blood flow in schizophrenic adolescents. Am J Psychiatry. 1986;143:130.
20. Guenther W, Moser E, Mueller-Spahn F, von Oefele K, Buell U, Hippius H. Pathological cerebral blood flow during motor function in schizophrenic and endogenous depressed patients. Biol Psychiatry. 1986;21:889-899.
21. Weinberger DR, Berman KF, Zec RF. Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia, I: regional cerebral blood flow (rCBF) evidence. Arch Gen Psychiatry. 1986;43:114-124.
22. Geraud G, Arne-Bes MC, Guell A, Bes A. Reversibility of hemodynamically hypofrontality in schizophrenia. J Cereb Blood Flow Metab. 1987;7:9-12.
23. Berman KF, Illowsky BP, Weinberger DR. Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia, IV: further evidence for regional and behavioral specificity. Arch Gen Psychiatry. 1988;45:616-622.
24. Dousse M, Mamo H, Ponsin JC, Dinh YT. Cerebral blood flow in schizophrenia. Exp Neurol. 1988;199:98-111.
25. Mathew RJ, Wilson WH, Tant SR, Robinson L, Prakash R. Abnormal resting regional cerebral blood flow patterns and their correlates in schizophrenia. Arch Gen Psychiatry. 1988;45:542-549.
26. Weinberger DR, Berman KF, Illowsky BP. Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia, III: a new cohort and evidence for a monoaminergic mechanism. Arch Gen Psychiatry. 1988;45:609-615.
27. Bajc M, Medved V, Basic M, Topuzovic N, Babic D. Cerebral perfusion inhomogeneities in schizophrenia demonstrated with single-photon emission computed tomography and Tc99m-hexamethylpropyleneamineoxim. Acta Psychiatr Scand. 1989;80:427-433.
28. Cohen RM, Semple WE, Gross M, Nordahl TE, King AC, Pickar D, Post RM. Evidence for common alterations in cerebral glucose metabolism in major affective disorders and schizophrenia. Neuropsychopharmacology. 1989;2:241-254.
29. Erbas B, Kumbasar H, Erbengi G, Bekdik C. Tc-99m HMPAO/SPECT determination of regional cerebral blood flow changes in schizophrenics. Clin Nucl Med. 1990;12:904-907.
30. Paulman RG, Devous MD, Gregory RR, Herman JH, Jennings L, Bonte FJ, Nasrallah HA, Raese JD. Hypofrontality and cognitive impairment in schizophrenia: dynamic single-photon tomography and neuropsychological assessment of schizophrenic brain function. Biol Psychiatry. 1990;27:377-399.
31. Sagawa K, Kawakatsu S, Shibuya I Oiji A, Morinobu S, Komatani A, Yazaki M, Totsuka S. Correlation of regional cerebral blood flow with performance on neuropsychological tests in schizophrenic patients. Schizophr Res. 1990;3:241-246.
32. Warkentin S, Nilsson A, Risberg J, Karlson S, Flekkoy K, Franzen G, Gustafson L, Rodriguez G. Regional cerebral blood flow in schizophrenia: repeated studies during a psychotic episode. Psychiatry Res. 1990;35:27-38.
33. Wood FB, Flowers DL. Hypofrontal vs hypo-Sylvian blood flow in schizophrenia. Schizophr Bull. 1990;16:413-424.
34. Buchsbaum MS, Ingvar DH, Kessler R, Waters RN, Capelletti J, Kammen DP, King C, Johnson J, Manning RG, Flynn RW, Mann LS, Bunney WE, Sokoloff L. Cerebral glucography with positron tomography. Arch Gen Psychiatry. 1982;39:251-259.
35. Sheppard G, Gruyzelier J, Manchanda R, Hirsch SR. 15-O—Positron emission tomographic scanning in predominantly never-treated acute schizophrenic patients. Lancet. 1983;2:1448-1452.
36. Buchsbaum MS, DeLisi LE, Holcomb HH, Cappelletti J, King AC, Johnson J, Hazlett E, Dowling-Zimmerman S, Post RM, Morihisa J, Carpenter W, Cohen R, Pickar D, Weinberger DR, Margolin R, Kessler RM. Anteropos- terior gradients in cerebral glucose use in schizophrenia and affective disorders. Arch Gen Psychiatry. 1984;41:1159-1166.
37. Farkas T, Wolf AP, Jaeger J, Brodie JD, Christman DR, Fowler JS. Regional brain glucose metabolism in chronic schizophrenia: a positron emission transaxial tomographic study. Arch Gen Psychiatry. 1984;41:293-300.
38. Wolkin A, Jaeger J, Brodie JD, Wolf AP, Fowler J, Rostrosen J, GomezMont F, Cancro R. Persistence of cerebral metabolic abnormalities in chronic schizophrenia as determined by positron emission tomography. Am J Psychiatry. 1985;142:564-571.
39. Jernigan TL, Sargent T, Pfefferbaum A, Kusubov N, Stahl SM. 18-Fluorodeoxyglucose PET in schizophrenia. Psychiatry Res. 1985;16:317-329.
40. Bustany P, Henry JF, Rotrou JD, Signoret P, Cabania E, Zarifian E, Siegler M, Darlon JM, Crouzel C, Soussaline F, Comar D. Correlations between clinical state and positron emission tomography measurement of local brain protein synthesis in Alzheimer's dementia, Parkinson's disease, schizophrenia, and gliomas. In: Greitz T, Ingvar DH, Widen L, eds. The Metabolism of the Human Brain Studied With Positron Emission Tomography. New York, NY: Raven Press; 1985:241-251.
41. Kling AS, Metter EJ, Riege WH, Kuhl DE. Comparison of PET measurement of local brain glucose metabolism and CAT measurement of brain atrophy in chronic schizophrenia and depression. Am J Psychiatry. 1986;143:175-180.
42. Volkow ND, Brodie JD, Wolf AP, Angrist B, Russell J, Cancro R. Brain metabolism in patients with schizophrenia before and during neuroleptic administration. J Neurol Neurosurg Psychiatry. 1986;49:1199-1202.
43. Early TS, Reiman EM, Raichle ME, Spitznagel EL. Left globus pallidus abnormality in never-medicated patients with schizophrenia. Proc Natl Acad Sci U S A. 1987;84:561-563.
44. Gur RE, Resnick SM, Alavi A, Gur RC, Caroff S, Dann R, Silver FL, Saykin AJ, Chawluk JB, Kushner M, Reivich M. Regional brain function in schizophrenia, I: a positron emission tomography study. Arch Gen Psychiatry. 1987;44:119-125.
45. Volkow ND, Wolf AP, Van Gelder P, Brodie JD, Overall JE, Cancro R, Gomez-Mont F. Phenomenological correlates of metabolic activity in 18 patients with chronic schizophrenia. Am J Psychiatry. 1987;144:151-158.
46. Cohen RM, Gross M, Nordahl TE, DeLisi LE, Holcomb HH, King AC, Morihisa JM, Pickar D. Dysfunction in a prefrontal substrate of sustained attention in schizophrenia. Life Sci. 1987;40:2031-2039.
47. Kishimoto H, Kuwahara H, Ohno S, Takazu O, Hama Y, Sato C, Ishii T, Nomura Y, Fujita H, Miyauchi T, Matsushita M, Yokoi S, lio M. Three subtypes of chronic schizophrenia identified using 11C-glucose positron emission tomography. Psychiatry Res. 1987;21:285-292.
48. Wiesel FA, Wik G, Sjogren I, Blomqvist G, Greitz T. Altered relationships between metabolic rates of glucose in brain regions of schizophrenic patients. Acta Psychiatr Scand. 1987;76:642-647.
49. Wolkin A, Angrist B, Wolf A, Brodie JD, Wolkin B, Jaeger J, Cancro R, Rotrosen J. Low frontal glucose utilization in chronic schizophrenia: a replication study. Am J Psychiatry. 1988;145:251-253.
50. Szechtman H, Nahmias C, Garnett S, Firnau G, Brown GM, Kaplan RD, Cleghorn JM. Effect of neuroleptics on altered cerebral glucose metabolism in schizophrenia. Arch Gen Psychiatry. 1988;45:523-532.
51. Cleghorn JM, Garnett ES, Nahmias C, Firman G, Brown GM, Kapalan RD, Szechtman H, Szechtman B. Increased frontal and reduced parietal glucose metabolism in acute untreated schizophrenia. Psychiatry Res. 1989;28:119-133.
52. Buchsbaum MS. The frontal lobes, basal ganglia, and temporal lobes as sites for schizophrenia. Schizophr Bull. 1990;16:379-389.
53. Andreasen NC. Negative symptoms in schizophrenia: definition and reliability. Arch Gen Psychiatry. 1982;39:784-788.
54. Andreasen NC, Nasrallah HA, Dunn VD, Olson SC, Grove WM, Ehrhardt JC, Coffman JA, Crossett JHW. Structural abnormalities in the frontal system in schizophrenia: a magnetic resonance imaging study. Arch Gen Psychiatry. 1986;43:136-144.
55. Andreasen NC. Brain imaging: applications in psychiatry. Science. 1988;239:1381-1388.
56. Andreasen NC. The Scale for the Assessment of Negative Symptoms (SANS): conceptual and theoretical foundations. BrJ Psychiatry. 1989;155 (suppl 7):49-52.
57. Andreasen NC. Neural mechanisms of negative symptoms. Br J Psychiatry. 1989;155(suppl 7):93-98.
58. Rosvold HE, Mirsky AF, Sarason I, Bransome ED Jr, Beck LH. A continuous performance test of brain damage. J Consult Clin Psychol. 1956;20:343-350.
59. Berg EA. A simple objective technique for measuring flexibility in thinking. J Gen Psychol. 1948;39:15-22.
60. Raven JC. Advanced Progressive Matrices Sets I and II: Plan and Use of the Scale With a Report of Experimental Work. London, England: Lewis HK; 1965.
61. Andreasen NC. Comprehensive Assessment of Symptoms and History (CASH). Iowa City, Iowa: The University of Iowa; 1985.
62. Hamilton M. A rating scale for depression. J Psychiatry Neurol Neurosurg. 1960;23:56.
63. Hamilton M. Diagnosis and rating of anxiety. Br J Psychiatry. 1969;3:76-79.
64. Overall J, Gorham D. Brief Psychiatric Rating Scale. Psychol Rep. 1962;10:799-812.
65. Department of Health, Education, and Welfare. Abnormal Involuntary Movement Scale. Washington, DC: HEW Alcohol Drug Abuse and Health Administration; 1974.
66. Simpson GM, Angus JWS. A rating scale for extrapyramidal side effects. Acta Psychiatr Scand. 1970;1(suppl):212.
67. Andreasen NC. The Scale for the Assessment of Negative Symptoms (SANS). Iowa City, Iowa: The University of Iowa; 1983.
68. Andreasen NC. The Scale for the Assessment of Positive Symptoms (SAPS). Iowa City, Iowa: The University of Iowa; 1984.
69. Endicott J, Spitzer RL, Fleiss JL, Cohen J. The Global Assessment Scale: a procedure for measuring overall severity of psychiatric disturbance. Arch Gen Psychiatry. 1976;33:766-771.
70. Stokely EM, Sveinsdottir E, Lassen NA, Rommer P. A single-photon dynamic computer assisted tomograph (DCAT) for imaging brain function in multiple cross sections. J Comput Assist Tomogr. 1980;4:230-240.
71. Rezai K, Kirchner P, Armstrong C, Ehrhardt JC, Heistad D. Validation studies for brain blood flow assessment by radioxenon tomography. J Nucl Med. 1988;29:348-355.
72. Kanno I, Lassen NA. Two methods for calculating cerebral blood flow from emission computed tomography in inert gas concentrations. J Comput Assist Tomogr. 1979;3:71-76.
73. Kanno I, Uemura K, Miura S, Takahaski S, Kawata Y. Evaluation of methods for calculating regional cerebral blood flow from tomographic data of Xe-133 concentration. J Cereb Blood Flow Metab. 1981;1:S21-S22.
74. Celsis P, Goldman T, Henricksen L, Lassen NA. A method for calculating regional cerebral blood flow from emission computed tomography of inert gas concentrations. J Comput Assist Tomogr. 1981;5:641-645.
75. Shallice T. Specific impairments of planning. Philos Trans R Soc Lond Biol. 1982;298:199-209.
76. Fox PT, Mintun MA, Raichle ME, Miezin FM, Allman JM, Van Essen DC. Mapping human visual cortex with positron emission tomography. Nature. 1986;323:806-809.
77. Petersen SE, Fox PT, Posner MI, Mintun M, Raichle ME. Positron emission tomographic studies of cortical anatomy of single-word processing. Nature. 1988;331:585-589.
78. Pardo JV, Pardo PJ, Janer KW, Raichle ME. The anterior cingulate cortex mediates processing selection in the Stroop attentional conflict paradigm. Proc Natl Acad Sci U S A. 1990;1:256-259.
79. Fox PT. Physiological ROI definition by image subtraction. J Cereb Blood Flow Metab. 1991;11:A79-82.
80. Levy AV, Laska E, Brodie JD, Volkow ND, Wolf AP. The spectral signature method for the analysis of PET brain images. J Cereb Blood Flow Metab. 1991;11:103-113.
81. Matsui T, Hirano A. An Atlas of the Human Brain for Computerized Tomography. New York, NY: Igaku-Shoin Medical Publishers Inc; 1978.
82. Carpenter WT Jr, Heinrichs DW, Wagman AMI. Deficit and nondeficit forms of schizophrenia: the concept. AmJ Psychiatry. 1988;145:578-583.
83. Wong DF, Wagner HN Jr, Tune LE, Dannals RF, Pearlson GD, Links JM, Wilson AA, Toung JKT, Malat J, Williams JA, O'Tuama LA, Snyder SH, Kuhar MJ, Gjedde A. Positron emission tomography reveals elevated D2 dopamine receptors in drug-naive schizophrenics. Science. 1986;234:1558-1563.
84. Rezai K, Kirchner P, Armstrong C, Ehrhardt JC, Damasio H, Adams H, Damasio A. Regional cerebral blood flow (rCBF) measurements by SPECT analysis of xenon-133 transit: validation of technique and clinical correlation. J Nucl Med. 1984:25.
85. Andreasen NC, Cohen G, Harris G, Cizadlo T, Parkkinen J, Rezai K, Swayze VWII. Image processing for the study of brain structure and function: problems and programs. J Neuropsychiatry Clin Neurosci. 1992;4:125-133.
86. Raichle ME, Herscovitch P, Mintun MA, Martin WRW, Powers W. Dynamic measurements of local blood flow and metabolism in the study of higher cortical function in humans with positron emission tomography. Ann Neurol. 1984;15(suppl):S48-S49.
87. Mazziotta JC, Huang S-C, Phelps ME, Carson RE, MacDonald NS, Mahoney K. A noninvasive positron computed tomography technique using oxygen-15—labeled water for the evaluation of neurobehavioral task batteries. J Cereb Blood Flow Metab. 1985;5:70-78.